Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Disruption of estrogen receptor beta's DNA binding domain impairs its tumor suppressive effects in triple negative breast cancer.
Front Med (Lausanne). 2023 Feb 28;10:1047166. doi: 10.3389/fmed.2023.1047166. eCollection 2023.
Front Med (Lausanne). 2023.
PMID: 36926316
Free PMC article.
Estrogen receptor beta repurposes EZH2 to suppress oncogenic NFκB/p65 signaling in triple negative breast cancer.
Aspros KGM, Carter JM, Hoskin TL, Suman VJ, Subramaniam M, Emch MJ, Ye Z, Sun Z, Sinnwell JP, Thompson KJ, Tang X, Rodman EPB, Wang X, Nelson AW, Chernukhin I, Hamdan FH, Bruinsma ES, Carroll JS, Fernandez-Zapico ME, Johnsen SA, Kalari KR, Huang H, Leon-Ferre RA, Couch FJ, Ingle JN, Goetz MP, Hawse JR.
Aspros KGM, et al. Among authors: rodman epb.
NPJ Breast Cancer. 2022 Feb 17;8(1):20. doi: 10.1038/s41523-022-00387-0.
NPJ Breast Cancer. 2022.
PMID: 35177654
Free PMC article.
Item in Clipboard
Nuclear GSK-3β and Oncogenic KRas Lead to the Retention of Pancreatic Ductal Progenitor Cells Phenotypically Similar to Those Seen in IPMN.
Ding L, Roeck K, Zhang C, Zidek B, Rodman E, Hernandez-Barco Y, Zhang JS, Bamlet W, Oberg A, Zhang L, Bardeesy N, Li H, Billadeau D.
Ding L, et al.
Front Cell Dev Biol. 2022 May 13;10:853003. doi: 10.3389/fcell.2022.853003. eCollection 2022.
Front Cell Dev Biol. 2022.
PMID: 35646902
Free PMC article.
Item in Clipboard
Cite
Cite